Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Shanghai Stock Exchange 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Market Capitalization on January 14, 2025: USD 1.58 B

Zhejiang Jiuzhou Pharmaceutical Co., Ltd Market Capitalization is USD 1.58 B on January 14, 2025, a -41.56% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Zhejiang Jiuzhou Pharmaceutical Co., Ltd 52-week high Market Capitalization is USD 2.71 B on January 15, 2024, which is 71.13% above the current Market Capitalization.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 52-week low Market Capitalization is USD 1.50 B on August 23, 2024, which is -5.02% below the current Market Capitalization.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd average Market Capitalization for the last 52 weeks is USD 1.93 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 603456.SS

Zhejiang Jiuzhou Pharmaceutical Co., Ltd

CEO	Mr. Yi Jiang Mei
IPO Date	Oct. 10, 2014
Location	China
Headquarters	99 Waisha Road
Employees	4,877
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Key trends

Past 5 years